Oncolytics Biotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -22 | -79 | |
EBITDA | -9,265 | -9,651 | -9,877 |
EBIT | -9,281 | -2,857 | -9,944 |
Net Income | -9,243 | -9,177 | -10,346 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -7,299 | -6,734 | -6,834 |
Cash | 5,493 | 5,202 | 12,352 |
Basic Shares | 112,292 | 108,021 | 101,315 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -70 | -87 | -298 | -301 |
EBITDA | -28,655 | -25,455 | -25,168 | -19,549 |
EBIT | -28,725 | -25,542 | -25,471 | -19,837 |
Net Income | -28,759 | -22,794 | -20,919 | -18,298 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,118 | -20,057 | -21,450 | -17,248 |
Cash | 7,137 | 15,942 | 34,912 | 11,666 |
Basic Shares | 95,857 | 76,482 | 67,624 | 58,029 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.08 |
2026-03-31 | -$0.11 |
2025-12-31 | $0 |
2025-09-30 | -$0.14 |